3β-Methoxy-pregnenolone (MAP4343) as an innovative therapeutic approach for depressive disorders

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 5, 2012, Pages 1713-1718

  Bianchi, Massimiliano ^a   Baulieu, Etienne Emile ^a  

^a Mapreg SAS   (France)

Author keywords

Cytoskeleton; Mood disorders; Neurosteroids

Indexed keywords

3 BETA METHOXY PREGNENOLONE; ALPHA TUBULIN; FLUOXETINE; MAP 4343; PREGNENOLONE; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG DETERMINATION; DRUG EFFICACY; FORCED SWIMMING TEST; HIPPOCAMPUS; IMMOBILIZATION; MALE; MICROTUBULE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DEPRESSION; MALE; PREGNENOLONE; RATS; RATS, SPRAGUE-DAWLEY; TUBULIN;

RATTUS;

EID: 84857133982     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1121485109     Document Type: Article

References (31)

1. O'Donnell JM, Shelton RC (2011) Drug therapy of depression and anxiety disorders. Goodman and Gilman's The Pharmacological Basis of Therapeutics, eds Brunton L, Chabner B, Chabner B, Knollman B (McGraw-Hill, New York), 12th Ed, pp 397-415.
2. Blier P, de Montigny C (1994) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15:220-226. (Pubitemid 24210726)
3. Rush AJ, et al. (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Am J Psychiatry 163:1905-1917. (Pubitemid 44807782)
4. Bianchi M, Hagan JJ, Heidbreder CA (2005) Neuronal plasticity, stress and depression: Involvement of the cytoskeletal microtubular system? Curr Drug Targets CNS Neurol Disord 4:597-611. (Pubitemid 41448385)
5. Bianchi M, et al. (2006) Isolation rearing induces recognition memory deficits accompanied by cytoskeletal alterations in rat hippocampus. Eur J Neurosci 24:2894-2902. (Pubitemid 44813840)
6. Bianchi M, et al. (2009) Fluoxetine administration modulates the cytoskeletal microtubular system in the rat hippocampus. Synapse 63:359-364.
7. Conde C, Cáceres A (2009) Microtubule assembly, organization and dynamics in axons and dendrites. Nat Rev Neurosci 10:319-332.
8. Janke C, Kneussel M (2010) Tubulin post-translational modifications: Encoding functions on the neuronal microtubule cytoskeleton. Trends Neurosci 33:362-372.
9. Murakami K, Fellous A, Baulieu EE, Robel P (2000) Pregnenolone binds to microtubule- associated protein 2 and stimulates microtubule assembly. Proc Natl Acad Sci USA 97:3579-3584. (Pubitemid 30183345)
10. Fontaine-Lenoir V, et al. (2006) Microtubule-associated protein 2 (MAP2) is a neurosteroid receptor. Proc Natl Acad Sci USA 103:4711-4716.
11. Duchossoy Y, David S, Baulieu EE, Robel P (2011) Treatment of experimental spinal cord injury with 3β-methoxy-pregnenolone. Brain Res 1403:57-66.
12. Cryan JF, Valentino RJ, Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29:547-569. (Pubitemid 40755456)
13. Fernando AB, Robbins TW (2011) Animal models of neuropsychiatric disorders. Annu Rev Clin Psychol 7:39-61.
14. Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res 31:47-59.
15. Walf AA, Frye CA (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2:322-328. (Pubitemid 47040046)
16. Hellemans KG, Benge LC, Olmstead MC (2004) Adolescent enrichment partially reverses the social isolation syndrome. Brain Res Dev Brain Res 150:103-115. (Pubitemid 38639815)
17. Brenes JC, Fornaguera J (2009) The effect of chronic fluoxetine on social isolation-induced changes on sucrose consumption, immobility behavior, and on serotonin and dopamine function in hippocampus and ventral striatum. Behav Brain Res 198:199-205.
18. Flood JF, Cherkin A (1987) Fluoxetine enhances memory processing in mice. Psychopharmacology (Berl) 93:36-43. (Pubitemid 17143724)
19. Vazquez-Palacios G, Bonilla-Jaime H, Velazquez-Moctezuma J (2004) Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with flouxetine. Pharmacol Biochem Behav 78:165-169. (Pubitemid 38670525)
20. Gordon JA, Hen R (2004) The serotonergic system and anxiety. Neuromolecular Med 5:27-40. (Pubitemid 38391954)
21. Vázquez-Palacios G, Bonilla-Jaime H, Velázquez-Moctezuma J (2005) Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. Prog Neuropsychopharmacol Biol Psychiatry 29:39-46.
22. Yang C, Wang G, Wang H, Liu Z, Wang X (2009) Cytoskeletal alterations in rat hippocampus following chronic unpredictable mild stress and re-exposure to acute and chronic unpredictable mild stress. Behav Brain Res 205:518-524.
23. Moreira CM, Masson S, Carvalho MC, Brandão ML (2007) Exploratory behaviour of rats in the elevated plus-maze is differentially sensitive to inactivation of the basolateral and central amygdaloid nuclei. Brain Res Bull 71:466-474. (Pubitemid 46149197)
24. Bessa JM, et al. (2009) The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 14: 764-773, 739.
25. Barker GR, Warburton EC (2011) When is the hippocampus involved in recognition memory? J Neurosci 31:10721-10731.
26. Fuchs E, Flugge G, Czeh B (2006) Remodeling of neuronal networks by stress. Front Biosci 11:2746-2758. (Pubitemid 43806576)
27. Fournet V, et al. (2010) The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network. J Neurochem 115:1579-1594.
28. Ladurelle N, et al. (2011) Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC. Psychopharmacology (Berl), 10.1007/s00213-011- 2597-5.
29. Donati RJ, Rasenick MM (2005) Chronic antidepressant treatment prevents accumulation of gsalpha in cholesterol-rich, cytoskeletal-associated, plasma membrane domains (lipid rafts). Neuropsychopharmacology 30:1238-1245. (Pubitemid 40848078)
30. Davé RH, et al. (2011) A molecular and structural mechanism for G protein-mediated microtubule destabilization. J Biol Chem 286:4319-4328.
31. Clark RA, Shoaib M, Hewitt KN, Stanford SC, Bate ST (November 8, 2011) A comparison of InVivoStat with other statistical software packages for analysis of data generated from animal experiments. J Psychopharmacol, 10.1177/0269881111420313.